MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...

Monogram Technologies Inc. (NASDAQ:MGRM) (”Monogram” or the “Company”), an AI-driven robotics company focused on improving ...

Monogram gains FDA clearance for its robotic-assisted knee surgery system and plans clinical trials in India to expand ...

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th quarter and full year 2024 financial results ...

Analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics in a ...

We have seen 18 institutional investors add shares of $MGRM stock to their portfolio, and 7 decrease their positions in their most recent quarter.

Stock analysts at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics ...

Roth MKM raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares.Light Up your ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hyperfine (HYPR – Research Report) and Monogram Orthopaedics ...

AUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an ...